European Commission Enforcement in the Pharmaceutical Sector: Less Than Expected? The Boehringer Case Closure Suggests As Much
The implication appears to be that Boehringer had some case to answer, but the Commission chose not to pursue that case given the settlement. Sean-Paul Brankin (Crowell Moring)
When requesting a correction, please mention this item's handle: RePEc:cpi:atchrn:7.2.2012:i=7748. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Lindsay McSweeney)
If references are entirely missing, you can add them using this form.